| Henry J Krebs Iii, MD | |
|
600 Celebrate Life Pkwy, Cancer Treatment Centers Of America, Newnan, GA 30265-8001 | |
| (770) 400-6008 | |
| (404) 355-6959 |
| Full Name | Henry J Krebs Iii |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 43 Years |
| Location | 600 Celebrate Life Pkwy, Newnan, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043298243 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 027590 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southeastern Regional Medical Center | Newnan, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ctca Physicians Group Of Georgia, Llc. | 4880841212 | 119 |
News Archive
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
Ocimum Biosolutions today announced that its specialty life science Laboratory Information Management System (LIMS), Biotracker™ has been awarded the prestigious caBIG® (cancer Biomedical Informatics Grid®) Bronze Compatibility Certification by the National Cancer Institute, an institute of the National Institutes of Health, U.S. Department of Health and Human Services.
Results of the NRG Oncology clinical trial RTOG 1010 indicated that the addition of the monoclonal antibody trastuzumab to neoadjuvant trimodality treatment did not improve disease-free survival outcomes for patient with HER2 overexpressing local and locally advanced esophageal adenocarcinoma.
Women with breast cancer characterized by high levels of the protein HER2 and hormone receptors gained much less benefit from presurgery treatment with chemotherapy and HER2-targeted therapies if their cancer had one or more mutations in the PIK3CA gene, according to results presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
United States Senate Committee on Small Business and Entrepreneurship Chair Mary Landrieu, D-La., and Ranking Member Olympia J. Snowe, R-Maine, today held a hearing to better understand the needs of small businesses in health care reform and to examine whether the current proposals meet those needs
› Verified 5 days ago
| Entity Name | Ctca Physicians Group Of Georgia, Llc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447520333 PECOS PAC ID: 4880841212 Enrollment ID: O20120820001117 |
News Archive
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
Ocimum Biosolutions today announced that its specialty life science Laboratory Information Management System (LIMS), Biotracker™ has been awarded the prestigious caBIG® (cancer Biomedical Informatics Grid®) Bronze Compatibility Certification by the National Cancer Institute, an institute of the National Institutes of Health, U.S. Department of Health and Human Services.
Results of the NRG Oncology clinical trial RTOG 1010 indicated that the addition of the monoclonal antibody trastuzumab to neoadjuvant trimodality treatment did not improve disease-free survival outcomes for patient with HER2 overexpressing local and locally advanced esophageal adenocarcinoma.
Women with breast cancer characterized by high levels of the protein HER2 and hormone receptors gained much less benefit from presurgery treatment with chemotherapy and HER2-targeted therapies if their cancer had one or more mutations in the PIK3CA gene, according to results presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
United States Senate Committee on Small Business and Entrepreneurship Chair Mary Landrieu, D-La., and Ranking Member Olympia J. Snowe, R-Maine, today held a hearing to better understand the needs of small businesses in health care reform and to examine whether the current proposals meet those needs
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Henry J Krebs Iii, MD 600 Celebrate Life Pkwy, Cancer Treatment Centers Of America, Newnan, GA 30265-8001 Ph: (770) 400-6008 | Henry J Krebs Iii, MD 600 Celebrate Life Pkwy, Cancer Treatment Centers Of America, Newnan, GA 30265-8001 Ph: (770) 400-6008 |
News Archive
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
Ocimum Biosolutions today announced that its specialty life science Laboratory Information Management System (LIMS), Biotracker™ has been awarded the prestigious caBIG® (cancer Biomedical Informatics Grid®) Bronze Compatibility Certification by the National Cancer Institute, an institute of the National Institutes of Health, U.S. Department of Health and Human Services.
Results of the NRG Oncology clinical trial RTOG 1010 indicated that the addition of the monoclonal antibody trastuzumab to neoadjuvant trimodality treatment did not improve disease-free survival outcomes for patient with HER2 overexpressing local and locally advanced esophageal adenocarcinoma.
Women with breast cancer characterized by high levels of the protein HER2 and hormone receptors gained much less benefit from presurgery treatment with chemotherapy and HER2-targeted therapies if their cancer had one or more mutations in the PIK3CA gene, according to results presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
United States Senate Committee on Small Business and Entrepreneurship Chair Mary Landrieu, D-La., and Ranking Member Olympia J. Snowe, R-Maine, today held a hearing to better understand the needs of small businesses in health care reform and to examine whether the current proposals meet those needs
› Verified 5 days ago
Dr. Daniel Scott Faith, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 745 Poplar Road, Newnan, GA 32605 Phone: 770-400-1000 | |
Kent B Remley, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1665 Highway 34 E, Suite 100, Newnan, GA 30265 Phone: 770-252-7557 Fax: 770-252-7513 | |
Lillian Shakibnia, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 600 Celebrate Life Pkwy, Radiation Oncology Department, Newnan, GA 30265 Phone: 770-400-6000 | |
John R Mcnair Jr., MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 745 Poplar Road, Newnan, GA 32605 Phone: 770-400-1000 | |
Dr. Brannan Howard Hatfield, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 745 Poplar Road, Newnan, GA 32605 Phone: 770-400-1000 Fax: 404-686-5701 | |
Dr. William T Bottoms Jr., MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 745 Poplar Road, Newnan, GA 32605 Phone: 770-400-1000 |